Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,841 public trials 2,180 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT05726526

Conditions
Chronic Disease, Chronic Kidney Disease Stage 5, Disease Attributes, +12 more
Locations
  • St. Boniface Hospital Winnipeg, Manitoba, Canada
  • Chronic Disease Innovation Centre, Seven Oaks Hospital Winnipeg, Manitoba, Canada
  • Health Sciences Centre Winnipeg, Manitoba, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 29 locations
View Trial Details
Recruiting

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

NCT05758077

Conditions
Acute Kidney Injury, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Phoenix, Arizona, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 36 locations
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

NCT07456865

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Rosemark Women Care Specialists Idaho Falls, Idaho, United States
  • Urology of Saint Louis St Louis, Missouri, United States
  • Urology Specialists of the Carolinas Greensboro, North Carolina, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

NCT06897930

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 20 locations
View Trial Details

Related conditions